Literature DB >> 3009463

Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein.

G I Goldberg, S M Wilhelm, A Kronberger, E A Bauer, G A Grant, A Z Eisen.   

Abstract

We have determined the complete sequence of the cDNA clone representing the full size human skin collagenase mRNA. Collagenase is synthesized in preproenzyme form, Mr 54,092, with a 19 amino acid long signal peptide. The primary secretion products of the enzyme consist of a minor glycosylated form, Mr 57,000, and a major unmodified polypeptide of predicted Mr 51,929. Proteolytic activation of human skin procollagenase results in removal of 81 amino acid residues from the amino-terminal portion of the proenzyme. Both potential N-glycosylation sites are contained within the proteolytically activated form of the enzyme. The primary structure of the coding region of the presented clone is homologous to an oncogene-induced rat protein whose function is still unknown, although preliminary observations suggest that it is not rat skin collagenase.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3009463

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  123 in total

1.  Contraction of fibroblast-containing collagen gels: initial collagen concentration regulates the degree of contraction and cell survival.

Authors:  Y K Zhu; T Umino; X D Liu; H J Wang; D J Romberger; J R Spurzem; S I Rennard
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-01       Impact factor: 2.416

2.  Soluble Arg-Gly-Asp peptides reduce collagen accumulation in cultured rat hepatic stellate cells.

Authors:  H Iwamoto; H Sakai; K Kotoh; M Nakamuta; H Nawata
Journal:  Dig Dis Sci       Date:  1999-05       Impact factor: 3.199

Review 3.  MMPs and TIMPs--an historical perspective.

Authors:  J Frederick Woessner
Journal:  Mol Biotechnol       Date:  2002-09       Impact factor: 2.695

4.  Identification of Clostridium histolyticum collagenase hyperreactive sites in type I, II, and III collagens: lack of correlation with local triple helical stability.

Authors:  M F French; A Bhown; H E Van Wart
Journal:  J Protein Chem       Date:  1992-02

5.  Structural characterization of the mesangial cell type IV collagenase and enhanced expression in a model of immune complex-mediated glomerulonephritis.

Authors:  D H Lovett; R J Johnson; H P Marti; J Martin; M Davies; W G Couser
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

6.  Specificity of the anticollagenase action of tetracyclines: relevance to their anti-inflammatory potential.

Authors:  K Suomalainen; T Sorsa; L M Golub; N Ramamurthy; H M Lee; V J Uitto; H Saari; Y T Konttinen
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

7.  Structural gene and complete amino acid sequence of Vibrio alginolyticus collagenase.

Authors:  H Takeuchi; Y Shibano; K Morihara; J Fukushima; S Inami; B Keil; A M Gilles; S Kawamoto; K Okuda
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

8.  Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck.

Authors:  N Johansson; K Airola; R Grénman; A L Kariniemi; U Saarialho-Kere; V M Kähäri
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

9.  Fragments of human fibroblast collagenase. Purification and characterization.

Authors:  I M Clark; T E Cawston
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

10.  Expression of growth factors and their receptors in human esophageal carcinomas: regulation of expression by epidermal growth factor and transforming growth factor alpha.

Authors:  K Yoshida; H Kuniyasu; W Yasui; Y Kitadai; T Toge; E Tahara
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.